Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)
- 1 May 2003
- journal article
- editorial
- Published by Wolters Kluwer Health in Hypertension
- Vol. 41 (5) , 1006-1009
- https://doi.org/10.1161/01.hyp.0000070905.09395.f6
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- Major Outcomes in High-Risk Hypertensive Patients Randomized to Angiotensin-Converting Enzyme Inhibitor or Calcium Channel Blocker vs Diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)JAMA, 2002
- Rationale and Design for the Antihypertensive and Lipid Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)American Journal of Hypertension, 1996
- Treatment of Mild Hypertension StudyJAMA, 1993
- Single-Drug Therapy for Hypertension in Men -- A Comparison of Six Antihypertensive Agents with PlaceboNew England Journal of Medicine, 1993
- Effect of Enalapril on Mortality and the Development of Heart Failure in Asymptomatic Patients with Reduced Left Ventricular Ejection FractionsNew England Journal of Medicine, 1992
- Effect of Enalapril on Survival in Patients with Reduced Left Ventricular Ejection Fractions and Congestive Heart FailureNew England Journal of Medicine, 1991
- Genesis of arrhythmias in the failing heart and therapeutic implicationsThe American Journal of Cardiology, 1991
- Effect of Antihypertensive Drugs on Insulin, Glucose, and Lipid MetabolismDiabetes Care, 1991
- Blood pressure, stroke, and coronary heart disease: Part 1, prolonged differences in blood pressure: prospective observational studies corrected for the regression dilution biasPublished by Elsevier ,1990
- Diuretics, serum potassium and ventricular arrhythmias in the Multiple Risk Factor Intervention TrialThe American Journal of Cardiology, 1987